SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-052110
Filing Date
2020-09-25
Accepted
2020-09-25 17:08:31
Documents
1
Period of Report
2020-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3578
  Complete submission text file 0001209191-20-052110.txt   4901
Mailing Address 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10118
Business Address
Alam Kamran (Reporting) CIK: 0001793412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39536 | Film No.: 201200897

Mailing Address 7318 MORTON STREET DALLAS TX 75209
Business Address 7318 MORTON STREET DALLAS TX 75209 212.551.8702
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences